In the context of viral infections, elevated levels of CXCL9 and CXCL10 have been linked to hyperinflammatory states and disease severity, particularly in respiratory infections such as influenza and COVID-19. This evidence concerns the gene CXCL9 and respiratory tract infectious disorder.